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staging must be performed in cases considered for surgical treatment 
even when positive mediastinal lymph nodes are detected in PET-CT. 
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Background: Nodular lymphoid hyperplasia (NLH) is one of the rare 
pulmonary lymphoproliferative disorders which may appear as a soli-
tary or multiple lesions. 
Method: A 61-year-old immunocompetent patient was admitted to our 
hospital with cough and hemoptysis. He was a heavy smoker without a 
history of tuberculosis. Physical examination was unremarkable. Chest 
X-ray demonstrated a mass located in the right middle zone. Thorax 
CT revealed a cavitary pulmonary mass (3x6 cm) and a satellite nodule 
localized to the superior segment of right lower lobe. In further evalu-
ation of the patient with bronchoscopy, endobronchial lesion could not 
be detected. The histopathological assessment of bronchoalveolar la-
vage, brush and aspiration ﬂuid were benign, and the smear was nega-
tive for tuberculosis. A second bronchoscopy to reach the diagnosis was 
uneventful and transthoracic needle aspiration revealed lymphocytes 
and leucocytes without an evidence of malignancy. Anti-tuberculosis 
therapy was initiated although the smear was negative for tuberculosis 
due to the high incidence of tuberculosis in our country. Four months 
later, he was referred from the local tuberculosis dispensary to our 
clinic with massive hemoptysis. Thorax CT showed that there was not 
any change of the lesion. Anti-tuberculosis therapy was stopped for 
the cultures for sputum and bronchoscopic materials were negative. 
Vasculitic syndromes, ie. Wegener’s granulomatosis were suspected 
in the presence of unidentiﬁed cavitary lesions. Myeloperoxidase and 
antiproteinase ANCA were negative. 
Result: FDG-PET standard uptake value was positive (SUV: 4.1), 
indicating malignancy. There was not any pathological FDG uptake 
in the other parts of the body. An open lung biopsy revealed the ﬁnal 
diagnosis of NLH, of which the histologic examination was positive for 
CD3, CD20 and LCA and negative for keratin. 
Conclusion: nodular lymphoid hyperplasia should be kept in mind 
in the differential diagnosis of the cavitary mass lesions with positive 
FDG uptake.
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Background: To correlate FDG uptake on PET/CT images with the 
expression of Glut-1 and Glut-3 glucose transporters in patients with 
non-small cell lung cancer (NSCLC).
Methods: Preoperative 18F-FDG PET/CT images were performed 
in 68 patients with non-small cell lung cancer. Final diagnoses were 
conﬁrmed by operative histology (37 adenocarcinoma, 28 squamous 
cell carcinoma, 2 large cell carcinoma and 1 pleomorphic carcinoma). 
The peak standardized uptake value (pSUV) of the lung cancer FDG 
uptake was measured and correlated to immunohistochemistry results 
for Glut-1 and Glut-3. In the immunohistochemical studies, (1) the in-
tensity of the immunoreactivity (grade 0 to3) and (2) percentage of the 
area testing positive (<25%; 26~50%; 51%~75%; <100%) for Glut-1 
and Glut-3 were reviewed. 
Results: The mean pSUV was 9.26±3.85 in squamous cell carcinoma, 
and 6.03±4.20 in adenocarcinoma. Intense FDG uptake of pSUV above 
8.0 was seen in 2 large cell carcinoma and one pleomorphic carcinoma 
cases. Squamous cell carcinoma had signiﬁcantly higher mean pSUV 
than adenocarcinoma (p=0.002). The expression of Glut-1 was also sig-
niﬁcantly higher in squamous cell carcinoma than in adenocarcinoma 
for both the grade of intensity (p=0.000) and the percentage of positive 
area (p=0.000), whereas the expression of Glut-3 was not signiﬁcantly 
different between adenocarcinoma and squamous cell carcinoma. The 
degree of pSUVs demonstrated signiﬁcant correlation with the intensity 
(p=0.000) and percentage of positive area of Glut-1 (p=0.003), and 
with the intensity of Glut-3 (p=0.002). However, the percentage of 
Glut-3 positive area and pSUV had no signiﬁcant correlation (p=0.064).
Conclusions: This study indicates that squamous cell carcinomas have 
higher FDG uptake and Glut-1 expression than adenocarcinomas. The 
FDG uptake in NSCLC correlates with the intensity and percentage 
of positive area of Glut-1, and intensity of Glut-3, but not with the 
percentage of Glut-3 positive area.
P1-103 Imaging and Staging Posters, Mon, Sept 3 
Clinical value of computed tomography and fluorine-18 
fluorodeoxyglucose positron remission tomography in diagnosis of 
mediastinal mestastasis of non-small cell lung cancer
Zhi, Xiuyi; Hu, Mu; Xu, Qingsheng; Zhang, Yi; Liu, Baodong 
Beijing Lung Cancer Centre CMU, Beijing, China
Background: TO compare the clinical value of computed tomography 
(CT) and ﬂuorine-18 ﬂuorodeoxyglucose positron remission tomog-
raphy (FDG-PET) in diagnosis of mediastinal metastasis of non-small 
cell lung cancer (NSCLC).
Methods: From 2004 to 2006 75 patients with respectable NSCLC un-
derwent CT and FDG-PET with an interval of 2 weeks and then under-
went thoracotomy for clearance of mediastinal lymph nodes or biopsy 
of the mediastinal lymph nodes via mediastinoscopy. The specimens 
of mediastinal lymph nodes underwent HE staining and PCNA/Ki67 
immunohistochemical staining.The sensitivity, speciﬁcity, accuracy, 
positive prediction value, and negative prediction value in diagnosis 
of metastasis of mediastinal lymph nodes of these 2 procedures were 
compared. 
Results: The sensitivity, speciﬁcity, accuracy, positive prediction value, 
and negative prediction value in diagnosis of metastasis of mediastinal 
lymph nodes were 91.2%, 85.5%, 94.2%, 93.1%, 73.1% respectively 
